COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 171 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,310,638 | +64.1% | 148,127 | +57.7% | 0.00% | 0.0% |
| Q2 2023 | $2,017,911 | +119.6% | 93,900 | +145.2% | 0.00% | – |
| Q1 2023 | $918,817 | -8.4% | 38,300 | -11.5% | 0.00% | – |
| Q4 2022 | $1,003,493 | +44.6% | 43,254 | -0.1% | 0.00% | – |
| Q3 2022 | $694,000 | -9.4% | 43,306 | +0.2% | 0.00% | – |
| Q2 2022 | $766,000 | -13.1% | 43,240 | -0.1% | 0.00% | – |
| Q1 2022 | $881,000 | +9.3% | 43,279 | +0.3% | 0.00% | – |
| Q4 2021 | $806,000 | -5.4% | 43,129 | -0.1% | 0.00% | – |
| Q3 2021 | $852,000 | -19.5% | 43,164 | -3.5% | 0.00% | – |
| Q2 2021 | $1,058,000 | -0.2% | 44,744 | 0.0% | 0.00% | – |
| Q1 2021 | $1,060,000 | +23.4% | 44,744 | +4.3% | 0.00% | – |
| Q4 2020 | $859,000 | -3.8% | 42,900 | 0.0% | 0.00% | – |
| Q3 2020 | $893,000 | -51.1% | 42,900 | -58.9% | 0.00% | -100.0% |
| Q2 2020 | $1,828,000 | +7.2% | 104,460 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,706,000 | -40.2% | 104,460 | -24.6% | 0.00% | -50.0% |
| Q4 2019 | $2,851,000 | +79.3% | 138,510 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $1,590,000 | -9.1% | 138,510 | +4.1% | 0.00% | 0.0% |
| Q2 2019 | $1,750,000 | +3.2% | 133,110 | +18.8% | 0.00% | 0.0% |
| Q1 2019 | $1,696,000 | +0.7% | 112,040 | +14.3% | 0.00% | 0.0% |
| Q4 2018 | $1,684,000 | +207.3% | 98,050 | +163.6% | 0.00% | – |
| Q3 2018 | $548,000 | -38.2% | 37,200 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $887,000 | -1.7% | 37,200 | +5.4% | 0.00% | 0.0% |
| Q1 2018 | $902,000 | +77.2% | 35,300 | +27.9% | 0.00% | – |
| Q4 2017 | $509,000 | +75.5% | 27,600 | 0.0% | 0.00% | – |
| Q3 2017 | $290,000 | -15.9% | 27,600 | 0.0% | 0.00% | – |
| Q2 2017 | $345,000 | +119.7% | 27,600 | +76.9% | 0.00% | – |
| Q1 2017 | $157,000 | -35.4% | 15,600 | 0.0% | 0.00% | – |
| Q4 2016 | $243,000 | +11.5% | 15,600 | +38.1% | 0.00% | – |
| Q3 2016 | $218,000 | +78.7% | 11,300 | +9.7% | 0.00% | – |
| Q2 2016 | $122,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |